Christian Torp-Petersen

Risk prediction is improved by adding markers of subclinical organ damage to SCORE

Thomas Sehestedt, Jørgen Jeppesen, Tine W. Hansen et al. · European Heart Journal · 2009 · 312 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Effect of Machine Learning on Dispatcher Recognition of Out-of-Hospital Cardiac Arrest During Calls to Emergency Medical Services

Stig Nikolaj Fasmer Blomberg, Helle Collatz Christensen, Freddy Lippert et al. · JAMA Network Open · 2021 · 130 citations · Full text

Health Professions, Emergency Medical Services, Emergency Medicine +17

Rationale and Design of ATHENA: <b>A</b> Placebo‐Controlled, Double‐Blind, Parallel Arm <b>T</b>rial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular <b>H</b>ospitalization or Death from Any Cause in Pati<b>EN</b>ts with <b>A</b>trial Fibrillation/Atrial Flutter

Stefan H. Hohnloser, Stuart J. Connolly, Harry J.G.M. Crijns et al. · Journal of Cardiovascular Electrophysiology · 2007 · 82 citations

Medicine, Cardiology, Pharmacology +14

The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure

Marina Harutyunyan, Michael Christiansen, Julia S. Johansen et al. · Immunobiology · 2011 · 68 citations

Veterinary Medicine, Cardiology, Immunology +9

The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)

Henrik Wiggers, Lars Køber, Gunnar Gislason et al. · American Heart Journal · 2020 · 30 citations · Full text

Medicine, Cardiology, Pharmacology +12